Last reviewed · How we verify
Yangxinshi mimic
Yangxinshi mimic is a traditional Chinese medicine-derived compound that modulates cardiac function and improves myocardial energy metabolism.
Yangxinshi mimic is a traditional Chinese medicine-derived compound that modulates cardiac function and improves myocardial energy metabolism. Used for Heart failure, Myocardial ischemia, Angina pectoris.
At a glance
| Generic name | Yangxinshi mimic |
|---|---|
| Sponsor | Shenyang Northern Hospital |
| Drug class | Traditional Chinese medicine derivative / cardiac protective agent |
| Modality | Small molecule |
| Therapeutic area | Cardiovascular |
| Phase | FDA-approved |
Mechanism of action
The drug is designed to enhance cardiac contractility and reduce myocardial ischemic injury through metabolic optimization. It acts on multiple pathways involved in cardiac protection, including mitochondrial function and cellular energy production, making it suitable for heart failure and ischemic heart disease management.
Approved indications
- Heart failure
- Myocardial ischemia
- Angina pectoris
Common side effects
- Gastrointestinal disturbance
- Dizziness
- Headache
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |